| Literature DB >> 22286507 |
Lisa M Schwartz1, Steven Woloshin, Alice Andrews, Therese A Stukel.
Abstract
OBJECTIVE: To determine whether the quality of press releases issued by medical journals can influence the quality of associated newspaper stories.Entities:
Mesh:
Year: 2012 PMID: 22286507 PMCID: PMC3267473 DOI: 10.1136/bmj.d8164
Source DB: PubMed Journal: BMJ ISSN: 0959-8138

Fig 1 Study selection of journal articles, press releases, and newspaper stories
Description of medical journal articles and associated newspaper stories, by journal. Data are number or number (%), unless indicated otherwise
| Medical journal | ||||||
|---|---|---|---|---|---|---|
| Annals | JNCI | BMJ | JAMA | NEJM | All | |
| Editorial policy | ||||||
| Editor notes included in articles | Yes | Yes | No | No | No | NA |
| Press releases issued | Yes | Yes | Yes | Yes | No | NA |
| All | 10 | 20 | 20 | 25 | 25 | 100 |
| Has abstract | 10 (100) | 20 (100) | 20 (100) | 25 (100) | 25 (100) | 100 (100) |
| Has editor note | 10 (100) | 19 (95) | 0 | 0 | 0 | 29 (29) |
| Study design | ||||||
| Meta-analyses | 0 | 2 (10) | 1 (5) | 6 (24) | 0 | 9 (9) |
| Randomised trials | 2 (20) | 3 (15) | 6 (30) | 9 (36) | 19 (76) | 39 (39) |
| Observational studies (with controls) | 8 (80) | 11 (55) | 13 (65) | 10 (40) | 3 (12) | 45 (45) |
| Observational studies (without controls) | 0 | 0 | 0 | 0 | 0 | 0 |
| Gene association studies | 0 | 1 (5) | 0 | 0 | 3 (12) | 4 (4) |
| Decision models | 0 | 1 (5) | 0 | 0 | 0 | 1 (1) |
| Animal studies | 0 | 2 (10) | 0 | 0 | 0 | 2 (2) |
| Study characteristics | ||||||
| No of participants (median, range)* | 2234 (65-61 752) | 8171 (413-2 788 715) | 1892 (25-161 808) | 3037 (57-152 084) | 1050 (18-259 387) | 2126 (18-2 788 715) |
| Industry funding | ||||||
| None | 8 (80) | 16 (80) | 15 (75) | 12 (48) | 5 (20) | 56 (56) |
| Of study | 2 (20) | 0 | 1 (5) | 1 (4) | 13 (52) | 17 (17) |
| Of investigators† | 0 | 4 (20) | 4 (20) | 12 (48) | 7 (28) | 27 (27) |
| Primary outcome surrogate | 2 (20) | 2 (10) | 1 (5) | 2 (8) | 1 (4) | 8 (8) |
| Beneficial intervention | 4 (40) | 6 (30) | 6 (30) | 11 (44) | 13 (52) | 40 (40) |
| Associated press release issued | 8 (80) | 20 (100) | 17 (85) | 23 (92) | 0 | 68 (68) |
| All | 51 | 104 | 232 | 201 | 171 | 759 |
| Reported in top 5 US circulation newspapers‡ | 4 (8) | 9 (9) | 6 (3) | 17 (8) | 20 (12) | 56 (7) |
| Reported in top 5 UK circulation newspapers§ | 1 (2) | 3 (3) | 18 (8) | 8 (4) | 6 (4) | 36 (5) |
| Stories appearing on page 1¶ | 3 (6) | 11 (11) | 8 (3) | 14 (7) | 28 (16) | 64 (8) |
| No of stories per journal article (median, range) | 2 (1-19) | 3 (1-34) | 5 (1-72) | 3 (1-34) | 2 (1-36) | 3 (1-72) |
| Random sample selected for quality assessment | 31 | 61 | 79 | 86 | 86 | 343 |
Medical journals are listed according to editorial policy. NA=not applicable.
*Includes 93 articles about primary human research (excluding secondary analyses of population data).
†Investigators disclosed personal funding support from industry (for example, as consultant or lecturer, in the form of honorariums or past salary support).
‡Newspapers with the highest circulation (daily and Sunday editions combined) in the USA in 2008, according to Burrelles-Luce (www.burrellesluce.com/top100/2008_Top_100List.pdf): the New York Times, Wall Street Journal, USA Today, Washington Post, and Los Angeles Times.
§ Newspapers with the highest circulation (daily and Sunday editions combined) in the UK in 2009, according to the Audit Bureau of Circulations (www.guardian.co.uk/media/page/abcs2009): the Sun, Daily Mirror and Sunday Mirror, Daily Mail and Sunday Mail, Sunday Times, and News of the World.
¶We could not determine the page number for 63 newspaper stories, so data might be underestimated.
Quality of reporting in journal article abstracts, journal press releases, and associated newspaper stories. Data are number or number (%)
| Quality measure | Quality measure reported | ||
|---|---|---|---|
| Abstracts | Press releases | Newspaper stories | |
| All | 100 | 68 | 343 |
| Accurate description of exposure* | NA | 68 (100) | 341 (99) |
| Accurate description of outcome* | NA | 67 (99) | 328 (96) |
| Study size mentioned | 94 (94) | 60 (88) | 258 (75) |
| Funding source mentioned | 2 (2) | 2 (3) | 39 (11) |
| Randomised trials | 45 | 22 | 157 |
| Randomised trials clearly identified | 43 (96) | 20 (91) | 30 (19) |
| Surveys | 10 | 10 | 39 |
| Survey response rate mentioned | 3 (30) | 2 (20) | 0 |
| Longitudinal studies | 87 | 57 | 291 |
| Timeframe mentioned | 72 (83) | 40 (70) | 160 (55) |
| All | 100 | 68 | 343 |
| Main result quantified | 99 (99) | 53 (78) | 240 (70) |
| Numbers used correctly† | NA | 49 (92) | 207 (86) |
| Main result quantified with absolute risks | 50 (50) | 23 (34) | 78 (23) |
| Studies of beneficial interventions | 40 | 23 | 133 |
| Harms mentioned‡ | 17 (43) | 8 (35) | 54 (41) |
| Harms quantified | 8 (20) | 3 (13) | 16 (12) |
| Harms quantified with absolute risks | 4 (10) | 2 (9) | 11 (8) |
| Studies with important research limitations§ | 75 | 57 | 256 |
| Any limitation mentioned | 53 (71) | 23 (40) | 73 (29) |
| Observational studies making causal claims | 43 | 34 | 147 |
| Confounding mentioned | 26 (60) | 9 (26) | 28 (19) |
| Studies with surrogate primary outcome | 18 | 11 | 60 |
| Clinical meaning of outcome mentioned | 6 (33) | 5 (45) | 13 (22) |
NA=not applicable.
*That is, whether the exposure or outcome in the press release matched those described in the journal abstract.
†Denominator is number of documents quantifying main result.
‡Also includes statements declaring that no harms were observed.
§Included any limitation mentioned in abstract, press release, or predefined list (web appendix).

Fig 2 Association between quality of medical journal press releases and quality of associated newspaper stories. Proportions (%) of stories with specific quality measures adjusted for whether measure was in journal article abstract or editor’s note. The quality measure of whether a randomised trial was clearly identified not included because the adjustment model would not converge (crude proportions of stories with measure: 0% (press release does not identify trial), 29% (press release identifies trial), and 9% (no press release)). *Significant association. †Relative risks with 0 as numerator or denominators calculated by Haldane’s method for bias correction of small samples18
Independent effect of quality measure in press releases and journal abstracts (or editor notes) on the quality of associated newspaper stories
| Quality measure | Newspaper stories reporting quality measure (%) | ||||||
|---|---|---|---|---|---|---|---|
| Quality measure in press release? | Quality measure in journal abstract? | ||||||
| Yes | No | Relative risk (95% CI) | Yes | No | Relative risk (95% CI) | ||
| All stories (n) | 217 | 28 | - | 325 | 18 | - | |
| Study size mentioned (%) | 78 | 37 | 2.1 (0.80 to 5.5) | 76 | 35 | 2.1 (0.88 to 5.2) | |
| All stories (n) | 238 | 7 | - | 331 | 12 | - | |
| Funding source mentioned (%) | 42 | 7 | 6.2 (1.4 to 27.0)* | 10 | 10 | 1.0 (0.24 to 4.5) | |
| Stories about randomised trials (n) | 82 | 8 | 325 | 18 | - | ||
| Randomised trial clearly identified (%)† | 29 | 0 | 5.3 (0.3 to 79) | 20 | 0 | 7.6 (0.5 to 118.7) | |
| Stories about longitudinal studies (n) | 158 | 47 | 254 | 37 | - | ||
| Time frame mentioned (%) | 58 | 21 | 2.7 (0.78 to 9.6) | 54 | 30 | 1.8 (0.79 to 4.1) | |
| All stories (n) | 203 | 42 | - | 337 | 6 | - | |
| Main result quantified (%) | 61 | 31 | 2.0 (1.1 to 3.7)* | 69 | 0 | 9.7 (0.7 to 140) | |
| All stories (n) | 77 | 168 | - | 159 | 184 | - | |
| Main result quantified with absolute risks (%) | 53 | 9 | 6.0 (2.3 to 15.4)* | 18 | 15 | 1.2 (0.59 to 2.4) | |
| Stories about beneficial interventions (n) | 30 | 54 | - | 62 | 71 | - | |
| Harms mentioned (%) | 68 | 24 | 2.8 (1.1 to 7.4)* | 43 | 30 | 1.5 (0.72 to 2.8) | |
| Stories about beneficial interventions (n) | 13 | 71 | - | 28 | 105 | - | |
| Harms quantified (%) | 18 | 3 | 5.5 (0.85 to 35.4) | 23 | 4 | 6.3 (2.6 to 15.6)* | |
| Stories about beneficial interventions (n) | 7 | 77 | - | 28 | 105 | - | |
| Harms quantified with absolute risks (%) | 43 | 3 | 14.1 (1.9 to 105)* | 19 | 4 | 4.9 (2.0 to 12.3)* | |
| Stories about studies with important research limitations (n) | 89 | 106 | - | 189 | 67 | - | |
| Limitation mentioned (%) | 48 | 17 | 3.0 (1.5 to 6.2)* | 28 | 18 | 1.6 (0.74 to 3.4) | |
| Stories about observational studies making causal claims (n) | 43 | 74 | - | 99 | 48 | - | |
| Confounding mentioned (%) | 24 | 10 | 2.5 (0.9 to 7.1) | 0 | 0 | 0.5 (0.1 to 24) | |
| Studies with surrogate primary outcome (n) | 20 | 22 | - | 22 | 38 | - | |
| Clinical meaning of outcome mentioned (%) | 40 | 0 | 18.6 (1.1 to 303)* | 0 | 0 | 1.7 (0.03 to 82.6) | |
Data are from models that include variables of both the press releases and journal abstracts and account for clustering within each journal. The quality measure of numbers quantifying main result correctly is not included since it is defined by what is in the abstract. Percentages are adjusted values according to whether relevant information was present in abstract or editor notes, unless indicated otherwise.
*Significant association.
†Crude values are presented because the adjustment model would not converge.
‡Relative risks with 0 as numerator or denominator were calculated by Haldane’s method for bias correction of small samples.24